Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer
Autotaxin (ATX) is a secreted enzyme that produces lysophosphatidate (LPA), which signals through six G-protein coupled receptors, promoting tumor growth, metastasis, and survival from chemotherapy and radiotherapy. Many cancer cells produce ATX, but breast cancer cells express little ATX. In breast...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/16/5938 |
_version_ | 1797557231109013504 |
---|---|
author | David N. Brindley Xiaoyun Tang Guanmin Meng Matthew G. K. Benesch |
author_facet | David N. Brindley Xiaoyun Tang Guanmin Meng Matthew G. K. Benesch |
author_sort | David N. Brindley |
collection | DOAJ |
description | Autotaxin (ATX) is a secreted enzyme that produces lysophosphatidate (LPA), which signals through six G-protein coupled receptors, promoting tumor growth, metastasis, and survival from chemotherapy and radiotherapy. Many cancer cells produce ATX, but breast cancer cells express little ATX. In breast tumors, ATX is produced by tumor-associated stroma. Breast tumors are also surrounded by adipose tissue, which is a major bodily source of ATX. In mice, a high-fat diet increases adipocyte ATX production. ATX production in obesity is also increased because of low-level inflammation in the expanded adipose tissue. This increased ATX secretion and consequent LPA signaling is associated with decreased adiponectin production, which results in adverse metabolic profiles and glucose homeostasis. Increased ATX production by inflamed adipose tissue may explain the obesity-breast cancer association. Breast tumors produce inflammatory mediators that stimulate ATX transcription in tumor-adjacent adipose tissue. This drives a feedforward inflammatory cycle since increased LPA signaling increases production of more inflammatory mediators and cyclooxygenase-2. Inhibiting ATX activity, which has implications in breast cancer adjuvant treatments, attenuates this cycle. Targeting ATX activity and LPA signaling may potentially increase chemotherapy and radiotherapy efficacy, and decrease radiation-induced fibrosis morbidity independently of breast cancer type because most ATX is not derived from breast cancer cells. |
first_indexed | 2024-03-10T17:14:24Z |
format | Article |
id | doaj.art-af6773ee69d84f18af65fc5fbf6026df |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-10T17:14:24Z |
publishDate | 2020-08-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-af6773ee69d84f18af65fc5fbf6026df2023-11-20T10:33:06ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-08-012116593810.3390/ijms21165938Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast CancerDavid N. Brindley0Xiaoyun Tang1Guanmin Meng2Matthew G. K. Benesch3Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2S2, CanadaDepartment of Biochemistry, University of Alberta, Edmonton, AB T6G 2S2, CanadaDepartment of Biochemistry, University of Alberta, Edmonton, AB T6G 2S2, CanadaDepartment of Biochemistry, University of Alberta, Edmonton, AB T6G 2S2, CanadaAutotaxin (ATX) is a secreted enzyme that produces lysophosphatidate (LPA), which signals through six G-protein coupled receptors, promoting tumor growth, metastasis, and survival from chemotherapy and radiotherapy. Many cancer cells produce ATX, but breast cancer cells express little ATX. In breast tumors, ATX is produced by tumor-associated stroma. Breast tumors are also surrounded by adipose tissue, which is a major bodily source of ATX. In mice, a high-fat diet increases adipocyte ATX production. ATX production in obesity is also increased because of low-level inflammation in the expanded adipose tissue. This increased ATX secretion and consequent LPA signaling is associated with decreased adiponectin production, which results in adverse metabolic profiles and glucose homeostasis. Increased ATX production by inflamed adipose tissue may explain the obesity-breast cancer association. Breast tumors produce inflammatory mediators that stimulate ATX transcription in tumor-adjacent adipose tissue. This drives a feedforward inflammatory cycle since increased LPA signaling increases production of more inflammatory mediators and cyclooxygenase-2. Inhibiting ATX activity, which has implications in breast cancer adjuvant treatments, attenuates this cycle. Targeting ATX activity and LPA signaling may potentially increase chemotherapy and radiotherapy efficacy, and decrease radiation-induced fibrosis morbidity independently of breast cancer type because most ATX is not derived from breast cancer cells.https://www.mdpi.com/1422-0067/21/16/5938adiponectinchemokineschemotherapycytokinesfibrosismacrophages |
spellingShingle | David N. Brindley Xiaoyun Tang Guanmin Meng Matthew G. K. Benesch Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer International Journal of Molecular Sciences adiponectin chemokines chemotherapy cytokines fibrosis macrophages |
title | Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer |
title_full | Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer |
title_fullStr | Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer |
title_full_unstemmed | Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer |
title_short | Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer |
title_sort | role of adipose tissue derived autotaxin lysophosphatidate signaling and inflammation in the progression and treatment of breast cancer |
topic | adiponectin chemokines chemotherapy cytokines fibrosis macrophages |
url | https://www.mdpi.com/1422-0067/21/16/5938 |
work_keys_str_mv | AT davidnbrindley roleofadiposetissuederivedautotaxinlysophosphatidatesignalingandinflammationintheprogressionandtreatmentofbreastcancer AT xiaoyuntang roleofadiposetissuederivedautotaxinlysophosphatidatesignalingandinflammationintheprogressionandtreatmentofbreastcancer AT guanminmeng roleofadiposetissuederivedautotaxinlysophosphatidatesignalingandinflammationintheprogressionandtreatmentofbreastcancer AT matthewgkbenesch roleofadiposetissuederivedautotaxinlysophosphatidatesignalingandinflammationintheprogressionandtreatmentofbreastcancer |